For all media queries please contact our Communications Advisor.
Medicines New Zealand is disappointed that patients will potentially miss out on a new medicine for a rare blood disorder known as PNH.
On Tuesday the Australian Government committed AU$691 million Dollars ($832 million NZ) over 5 years for new pharmaceutical investments - a forecast growth of 4.9%.
Dr Sally Eyers has won this year's Medicines New Zealand Value of Medicines Award for excellent research that is likely to vastly improve the safe use of a commonly used medicine.
The Trans Pacific Partnership (TPP) has provided an opportunity to benchmark the New Zealand medicines procurement system with its international peers.
Heather Roy is to Chair Medicines New Zealand, the industry association for innovative pharmaceutical companies in New Zealand.